Abstract | AIM: METHOD: One hundred and thirty-seven children with CTDs (108 males, 29 females; mean age [SD] 10y 0mo [2y 7mo], range 4-16y) were recruited over 18 months. Patients were assessed at baseline, at tic exacerbation, and at 2 months after exacerbation. Serum anti-D2R antibodies were evaluated using a cell-based assay and blinded immunofluorescence microscopy scoring was performed by two raters. The association between visit type and presence of anti-D2R antibodies was measured with McNemar's test and repeated-measure logistic regression models, adjusting for potential demographic and clinical confounders. RESULTS: At exacerbation, 11 (8%) participants became anti-D2R-positive ('early peri-exacerbation seroconverters'), and nine (6.6%) became anti-D2R-positive at post-exacerbation ('late peri-exacerbation seroconverters'). The anti-D2R antibodies were significantly associated with exacerbations when compared to baseline (McNemar's odds ratio=11, p=0.003) and conditional logistic regression confirmed this association (Z=3.49, p<0.001) after adjustment for demographic and clinical data and use of psychotropic drugs. INTERPRETATION: There is a potential association between immune mechanisms and the severity course of tics in adolescents with CTDs.
|
Authors | Francesco Addabbo, Valentina Baglioni, Anette Schrag, Markus J Schwarz, Andrea Dietrich, Pieter J Hoekstra, Davide Martino, Maura Buttiglione, Emtics Collaborative Group |
Journal | Developmental medicine and child neurology
(Dev Med Child Neurol)
Vol. 62
Issue 10
Pg. 1205-1212
(10 2020)
ISSN: 1469-8749 [Electronic] England |
PMID | 32644201
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 Mac Keith Press. |
Chemical References |
- Autoantibodies
- Receptors, Dopamine D2
|
Topics |
- Adolescent
- Autoantibodies
(blood)
- Child
- Child, Preschool
- Female
- Humans
- Male
- Receptors, Dopamine D2
(immunology)
- Tic Disorders
(blood, immunology)
|